Lv2
120 积分 2021-05-14 加入
Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer
2天前
已完结
Overall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer
2天前
已完结
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial
1个月前
已完结
Minimal residual disease as a target for liquid biopsy in patients with solid tumours
1个月前
已完结
De-escalation strategies for axillary management at primary surgery in early breast cancer: insights and implications for medical oncology practice
2个月前
已完结
Axillary Surgery for Patients With Residual Isolated Tumor Cells (ypN0i+) After Neoadjuvant Systemic Therapy for Early Breast Cancer
2个月前
已完结
Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial
2个月前
已完结
Endocrine Therapy Interruption, Resumption, and Outcomes Associated With Pregnancy After Breast Cancer
5个月前
已完结
Safety of pregnancy following breast cancer diagnosis: A meta-analysis of 14 studies
5个月前
已完结
Chemotherapy awakens dormant cancer cells in lung by inducing neutrophil extracellular traps
7个月前
已完结
皖公网安备34019202002308
